» Articles » PMID: 39474860

The Benefits and Accuracy of Real-time Continuous Glucose Monitoring in Children and Adolescents with Type 1 Diabetes Attending a Summer Camp

Overview
Specialty Endocrinology
Date 2024 Oct 30
PMID 39474860
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/introduction: This study evaluated the usability, satisfaction, and accuracy of a real-time continuous glucose monitoring (rt-CGM) in children and adolescents with type 1 diabetes (T1D) attending a summer camp.

Materials And Methods: Seven children and adolescents with T1D (camper) and 31 of healthcare providers (HCPs) participating in a 2-day summer camp in Kumamoto, Japan were enrolled. The usability and satisfaction were evaluated by tailored questionnaire. The accuracy of rt-CGM was evaluated using self-monitoring of blood glucose (BG) and sensor glucose (SG) values before or after (off camp) and during (on camp) the camp.

Results: The score of the usefulness of rt-CGM showed 3.29 ± 0.90 in campers and 4.23 ± 0.87 in HCPs (P = 0.017). The degree of recommendation score for rt-CGM was 3.29 ± 1.11 in campers and 4.23 ± 0.79 in HCPs (P = 0.013). Time in range (TIR) off camp was 45.9% and that on camp was 57.0%. Time above range (TAR) off camp was 53.4% and that on camp was 42.4%. The mean absolute relative difference (MARD) off camp was 19.7% ± 25.2%, whereas that on camp was 16.0% ± 14.8% (P = 0.367). Clinically acceptable zones of the error grid analyses were approximately 96% in total.

Conclusions: Rt-CGM exhibited higher usability and recommendation scores in HCPs than those in campers. This may be related to relatively lower accuracy in rt-CGM. Overall usability and recommendation are clinically satisfactory, but due to relatively low accuracy, no decision should be made based on a single, non-verified SG value alone.

Citing Articles

Continuous Glucose Monitoring-New Diagnostic Tool in Complex Pathophysiological Disorder of Glucose Metabolism in Children and Adolescents with Obesity.

Simunovic M, Kumric M, Rusic D, Paradzik Simunovic M, Bozic J Diagnostics (Basel). 2025; 14(24.

PMID: 39767162 PMC: 11674695. DOI: 10.3390/diagnostics14242801.

References
1.
Wong J, Foster N, Maahs D, Raghinaru D, Bergenstal R, Ahmann A . Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014; 37(10):2702-9. PMC: 4392936. DOI: 10.2337/dc14-0303. View

2.
Wagner J, Malchoff C, Abbott G . Invasiveness as a barrier to self-monitoring of blood glucose in diabetes. Diabetes Technol Ther. 2005; 7(4):612-9. DOI: 10.1089/dia.2005.7.612. View

3.
Rodbard D . Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther. 2016; 18 Suppl 2:S3-S13. PMC: 4717493. DOI: 10.1089/dia.2015.0417. View

4.
Ajjan R . How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?. Diabetes Technol Ther. 2017; 19(S2):S27-S36. PMC: 5444484. DOI: 10.1089/dia.2017.0021. View

5.
Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J . Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34(4):795-800. PMC: 3064030. DOI: 10.2337/dc10-1989. View